Differential requirement for STAT by gain-of-function and wild-type receptor tyrosine kinase Torso in Drosophila

Willis X Li1, Herve Agaisse, Bernard Mathey-Prevot

  • 1Department of Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA. willis_li@URMC.Rochester.edu

Development (Cambridge, England)
|August 17, 2002
PubMed

Insights

Receptor tyrosine kinases (RTKs) can activate Ras/Raf/MEK/MAPK signaling. However, gain-of-function mutant RTKs also require the JAK/STAT pathway, involving STAT, for ectopic gene expression.

Area of Science:

  • Cellular signaling pathways
  • Molecular oncology
  • Developmental biology

Background:

  • Receptor tyrosine kinases (RTKs) are crucial in cell signaling and frequently dysregulated in cancer.
  • While RTKs typically activate Ras/Raf/MEK/MAPK pathways, their overactivation can also engage the JAK/STAT pathway.
  • The precise role of the JAK/STAT pathway in RTK signaling, particularly in oncogenesis, remains incompletely understood.

Purpose of the Study:

  • To investigate the necessity of the JAK/STAT pathway for signaling mediated by wild-type and mutant forms of the Drosophila RTK Torso (Tor).
  • To elucidate the distinct signaling requirements for normal versus aberrant RTK activation.

Main Methods:

  • Utilized a genetic approach in Drosophila melanogaster.
  • Examined the signaling output of wild-type Tor and a gain-of-function mutant (Tor(GOF)).
  • Assessed the requirement for the JAK/STAT pathway component, STAT (encoded by marelle/mrl; DStat92E).

Main Results:

  • Signaling by wild-type Tor minimally or not at all depends on the JAK/STAT pathway.
  • STAT activation is essential for Tor(GOF) to induce ectopic gene expression.
  • The Ras/Raf/MEK/MAPK pathway is sufficient for wild-type RTK functions.

Conclusions:

  • Gain-of-function mutant RTK signaling exhibits distinct requirements compared to wild-type RTK signaling.
  • Aberrant RTK activation, unlike normal signaling, necessitates STAT activation in addition to Ras/Raf/MEK/MAPK pathway activity.
  • These findings highlight the context-dependent roles of signaling pathways in RTK-mediated cellular processes and cancer.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...